Wedgewood Pharmacy Recalls Compounded Animal Medications
Owners of companion and exotic animals should verify if their recent medication orders are part of this safety recall.
Updated on Oct. 21, 2026 in Pet Health
Live Poll
Do you trust that major pharmaceutical companies are transparent about drug safety and testing standards?
Wedgewood Pharmacy has issued a nationwide recall for certain compounded veterinary medications due to inconsistencies in laboratory testing data. The recall affects a wide range of product formats shipped to customers in the U.S. between February 18, 2026, and October 6, 2026.
Why it matters
Inconsistent testing data means medications may be subpotent or superpotent, potentially impacting the safety and treatment efficacy for pets and other animals. This recall was initiated to ensure owners of companion, equine, exotic, and zoo animals are not using potentially unreliable compounds.
The pharmacy has received 98 complaints about these medications, including 7 classified as serious. The recall covers products ranging from oral suspensions and injectables to topical sprays and ophthalmic solutions shipped nationwide over an eight-month period.
The players
Wedgewood Pharmacy
A Swedesboro, N.J.-based compounding pharmacy that prepares custom medications for companion and exotic animals.
U.S. Food and Drug Administration
The federal agency overseeing the safety of drugs and medical products which is currently aware of this recall.
Sedgwick
A claims management firm currently assisting with customer notifications and refund coordination for the recall.
The details
The recall stems from discrepancies in analytical testing data generated by the lab, which could result in products failing to meet potency standards. Because the compounds may be too strong or too weak, they pose a risk to the animals they are intended to treat. Sedgwick is managing the notification process, contacting impacted customers directly via email and mail to arrange for product refunds or replacements.
Timeline
Products were shipped to customers between February 18, 2026, and October 6, 2026.
The recall was issued on October 21, 2026.
The Home Front
This recall highlights the complexities of maintaining quality control for specialized, custom-compounded medications outside of mass-market pharmaceutical standards. It underscores the importance of adherence to the FDA's regulatory framework for compounded drugs to ensure animal safety.
If you have received compounded medications for your animal since February 2026, check your records or contact the pharmacy to verify if your specific product is impacted. You can find the list of affected recalled products online or call their dedicated recall services line at 866-562-5931.
The takeaway
Because these medications were intended for a wide variety of animals, owners should audit their medicine cabinets for any compounded items received since mid-February. Contact the recall services line at 866-562-5931 to confirm if your specific compound requires a return or replacement.
Further reading
For more information on ensuring your pets receive safe treatments, visit Pet Health.
More information
You can view the full list of affected recalled products on the pharmacy's official portal.
Live Poll
Do you trust that major pharmaceutical companies are transparent about drug safety and testing standards?
